199 related articles for article (PubMed ID: 24876355)
1. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.
Matsushita K; Sang Y; Ballew SH; Astor BC; Hoogeveen RC; Solomon SD; Ballantyne CM; Woodward M; Coresh J
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1770-7. PubMed ID: 24876355
[TBL] [Abstract][Full Text] [Related]
2. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
3. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
4. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
Astor BC; Shafi T; Hoogeveen RC; Matsushita K; Ballantyne CM; Inker LA; Coresh J
Am J Kidney Dis; 2012 May; 59(5):653-62. PubMed ID: 22305758
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Cardiovascular Biomarkers in the Population.
Neumann JT; Twerenbold R; Weimann J; Ballantyne CM; Benjamin EJ; Costanzo S; de Lemos JA; deFilippi CR; Di Castelnuovo A; Donfrancesco C; Dörr M; Eggers KM; Engström G; Felix SB; Ferrario MM; Gansevoort RT; Giampaoli S; Giedraitis V; Hedberg P; Iacoviello L; Jørgensen T; Kee F; Koenig W; Kuulasmaa K; Lewis JR; Lorenz T; Lyngbakken MN; Magnussen C; Melander O; Nauck M; Niiranen TJ; Nilsson PM; Olsen MH; Omland T; Oskarsson V; Palmieri L; Peters A; Prince RL; Qaderi V; Vasan RS; Salomaa V; Sans S; Smith JG; Söderberg S; Thorand B; Tonkin AM; Tunstall-Pedoe H; Veronesi G; Watanabe T; Watanabe M; Zeiher AM; Zeller T; Blankenberg S; Ojeda F
JAMA; 2024 Jun; 331(22):1898-1909. PubMed ID: 38739396
[TBL] [Abstract][Full Text] [Related]
6. Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.
Foster MC; Coresh J; Hsu CY; Xie D; Levey AS; Nelson RG; Eckfeldt JH; Vasan RS; Kimmel PL; Schelling J; Simonson M; Sondheimer JH; Anderson AH; Akkina S; Feldman HI; Kusek JW; Ojo AO; Inker LA;
Am J Kidney Dis; 2016 Jul; 68(1):68-76. PubMed ID: 26948990
[TBL] [Abstract][Full Text] [Related]
7. Early markers of cardiovascular risk in chronic kidney disease.
Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Incident Atrial Fibrillation in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Study.
Zelnick LR; Shlipak MG; Soliman EZ; Anderson A; Christenson R; Lash J; Deo R; Rao P; Afshinnia F; Chen J; He J; Seliger S; Townsend R; Cohen DL; Go A; Bansal N
Clin J Am Soc Nephrol; 2021 Jul; 16(7):1015-1024. PubMed ID: 34597264
[TBL] [Abstract][Full Text] [Related]
9. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
[TBL] [Abstract][Full Text] [Related]
10. Association of kidney function and albuminuria with prevalent and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) study.
Huang M; Matsushita K; Sang Y; Ballew SH; Astor BC; Coresh J
Am J Kidney Dis; 2015 Jan; 65(1):58-66. PubMed ID: 25151408
[TBL] [Abstract][Full Text] [Related]
11. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
[TBL] [Abstract][Full Text] [Related]
12. Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.
Inker LA; Coresh J; Sang Y; Hsu CY; Foster MC; Eckfeldt JH; Karger AB; Nelson RG; Liu X; Sarnak M; Appel LJ; Grams M; Xie D; Kimmel PL; Feldman H; Ramachandran V; Levey AS;
Clin J Am Soc Nephrol; 2017 Jan; 12(1):69-78. PubMed ID: 28062677
[TBL] [Abstract][Full Text] [Related]
13. Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure.
Tummalapalli SL; Zelnick LR; Andersen AH; Christenson RH; deFilippi CR; Deo R; Go AS; He J; Ky B; Lash JP; Seliger SL; Soliman EZ; Shlipak MG; Bansal N;
J Am Heart Assoc; 2020 Jul; 9(13):e014385. PubMed ID: 32578483
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.
Agarwala A; Virani S; Couper D; Chambless L; Boerwinkle E; Astor BC; Hoogeveen RC; Coresh J; Sharrett AR; Folsom AR; Mosley T; Ballantyne CM; Nambi V
Atherosclerosis; 2016 Oct; 253():156-163. PubMed ID: 27665201
[TBL] [Abstract][Full Text] [Related]
15. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
[TBL] [Abstract][Full Text] [Related]
17. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.
Folsom AR; Lutsey PL; Heckbert SR; Poudel K; Basu S; Hoogeveen RC; Cushman M; Ballantyne CM
J Thromb Haemost; 2018 Oct; 16(10):1964-1972. PubMed ID: 30007116
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Risk Prediction in CKD.
Ballew SH; Matsushita K
Semin Nephrol; 2018 May; 38(3):208-216. PubMed ID: 29753398
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.
Gori M; Gupta DK; Claggett B; Selvin E; Folsom AR; Matsushita K; Bello NA; Cheng S; Shah A; Skali H; Vardeny O; Ni H; Ballantyne CM; Astor BC; Klein BE; Aguilar D; Solomon SD
Diabetes Care; 2016 May; 39(5):677-85. PubMed ID: 26740635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
